ACAD
38.21
+0.07
+0.18%
AEMD
0.21
+0.02
+10.34%
APRI
2.46
+0.07
+3.05%
ARNA
4.29
+0.25
+6.06%
ATEC
1.5
-0.02
-1.32%
CFN
60.27
+0.14
+0.23%
CNAT
6.28
-0.04
-0.63%
CRXM
0.2
+0.01
+5.83%
CYTX
1.13
-0.07
-5.83%
DXCM
60.04
+0.99
+1.68%
GNMK
12.68
-0.1
-0.78%
HALO
15.67
+0.44
+2.89%
ILMN
192.71
-3.32
-1.69%
INNV
0.17
-0.02
-10.81%
INO
7.37
+0.32
+4.54%
ISCO
0.06
+0.00
+1.72%
ISIS
70.27
+1.61
+2.35%
LGND
67.52
+1.07
+1.61%
LPTN
2.93
-0.02
-0.68%
MBVX
1
+0.07
+7.53%
MEIP
5.5
-0.24
-4.18%
MNOV
3.61
-0.03
-0.69%
MRTX
24.34
+0.79
+3.35%
MSTX
0.56
+0.04
+7.43%
NBIX
41.42
+0.56
+1.37%
NUVA
45.03
+0.77
+1.74%
ONCS
0.38
+0.01
+1.34%
ONVO
5.84
+0.04
+0.69%
OREX
8.62
+0.98
+12.83%
OTIC
36.74
-0.13
-0.35%
QDEL
26
+0.19
+0.74%
RCPT
128.07
+3.08
+2.46%
RGLS
18.48
+0.19
+1.04%
RMD
64.92
+0.43
+0.67%
SCIE
0.03
+0.01
+17.17%
SPHS
0.8
+0.09
+13.07%
SRNE
13.58
+0.38
+2.88%
TROV
6.35
-0.01
-0.16%
VICL
1.01
+0.02
+1.81%
VOLC
17.99
0.00
0.00%
ZGNX
1.69
+0.02
+1.20%
Home » Events, Uncategorized

SDBDG BioTalk

Submitted by on September 27, 2009 – 2:16 pm

The Novelix Challenge: Developing Next Generation
Dermatology Drugs in a Low-Cost Virtual Environment
Burkhard Jansen, MD, PhD – CEO

September 30, 2009 5:30 – 8:00 pm (Announcements begin at 6:30 pm)

AT SORRENTO SUMMIT

Meetings are open to everyone and free of charge
[[Click here for more information.]]

Leave a comment!

Add your comment below, or trackback from your own site. You can also Comments Feed via RSS.

Be nice. Keep it clean. Stay on topic. No spam.

You can use these tags:

<a href="" title="" rel=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong> 

This is a Gravatar-enabled weblog. To get your own globally-recognized-avatar, please register at Gravatar.


6 × four =